These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10331036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of drug formulation on utilization and outcomes: Neoral and monitoring by sparse sample area under the curve.
    Belitsky P, Mahalati K, West K, Sketris I.
    Transplant Proc; 1999 May; 31(3):1667-8. PubMed ID: 10331038
    [No Abstract] [Full Text] [Related]

  • 5. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.
    Keown P, Niese D.
    Kidney Int; 1998 Sep; 54(3):938-44. PubMed ID: 9734620
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.
    Gaston R, Alloway RR, Gaber AO, Rossi SJ, Schroeder TJ, Irish WD, Canafax DM, First MR.
    Transplant Proc; 1999 Sep; 31(1-2):326-7. PubMed ID: 10083128
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Can three-times-a-day cyclosporine Neoral avoid cyclosporine toxicity in renal transplant recipients? A pharmacokinetic study.
    Swart N, Botha J, Tandon V, Michaels P, Pontin AR, Halkett J, Pascoe MD, Kahn D.
    Transplant Proc; 2001 Sep; 33(7-8):3140-1. PubMed ID: 11750349
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y, Zhang XD, Wang Y.
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
    Pamugas GE, Danguilan RA, Lamban AB, Mangati VB, Ona ET.
    Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590
    [Abstract] [Full Text] [Related]

  • 12. Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study Group.
    Barone G, Bunke CM, Choc MG, Hricik DE, Jin JH, Klein JB, Marsh CL, Min DI, Pescovitz MD, Pollak R, Pruett TL, Stinson JB, Thompson JS, Vasquez E, Waid T, Wombolt DG, Wong RL.
    Transplant Proc; 1996 Aug; 28(4):2183-6. PubMed ID: 8769194
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatment.
    Abendroth D, Buchholz B, Land W, May G, Wiesel M, Färber L, Korn A, Maibücher A.
    Transplant Proc; 1997 Aug; 29(1-2):275-6. PubMed ID: 9122993
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of microemulsion and conventional formulations of cyclosporine A in preventing acute rejection in de novo kidney transplant patients. The U.K. Neoral Renal Study Group.
    Pollard SG, Lear PA, Ready AR, Moore RH, Johnson RW.
    Transplantation; 1999 Nov 15; 68(9):1325-31. PubMed ID: 10573071
    [Abstract] [Full Text] [Related]

  • 17. Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.
    Korn A, Färber L, Maibücher A, Buchholz B, Offermann G.
    Transplant Proc; 1997 Nov 15; 29(7):2945-7. PubMed ID: 9365623
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Patient management by Neoral C(2) monitoring: an international consensus statement.
    Levy G, Thervet E, Lake J, Uchida K, Consensus on Neoral C(2): Expert Review in Transplantation (CONCERT) Group.
    Transplantation; 2002 May 15; 73(9 Suppl):S12-8. PubMed ID: 12023608
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.